Ignite Creation Date:
2024-05-06 @ 4:14 PM
Last Modification Date:
2024-10-26 @ 2:06 PM
Study NCT ID:
NCT04922853
Status:
RECRUITING
Last Update Posted:
2022-03-31
First Post:
2021-06-04
Brief Title:
Comparison of the Pathological Effect Between 2 and 4 Cycles Neoadjuvant CAPOX for LowIntermediate Risk IIIII Rectal Cancer
Sponsor:
West China Hospital
Organization:
West China Hospital
Organization Data
Organization:
West China Hospital
Class:
OTHER
Study ID:
RC-CT-2021
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
West China Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Ziqiang WangMD
Responsible Party Title:
professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
West China Hospital
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| The Third Peoples Hospital of Chengdu | OTHER |
| Chengdu Fifth Peoples Hospital | OTHER |
| Peking Union Medical College | OTHER |
| Peking University Cancer Hospital Institute | OTHER |
| Sun Yat-sen University | OTHER |
| Second Affiliated Hospital School of Medicine Zhejiang University | OTHER |
| Yunnan Cancer Hospital | OTHER |
| The First Affiliated Hospital of Zhengzhou University | OTHER |
| The Affiliated Hospital Of Guizhou Medical University | OTHER |
| Sichuan Provincial Peoples Hospital | OTHER |
| Nanchong Central Hospital | OTHER_GOV |
| Dazhou Central Hospital | OTHER |
| Leshan Peoples Hospital | UNKNOWN |
| GeneCast Biotechnology Co Ltd | INDUSTRY |